These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38961499)

  • 1. The impact of norepinephrine dose reporting heterogeneity on mortality prediction in septic shock patients.
    Morales S; Wendel-Garcia PD; Ibarra-Estrada M; Jung C; Castro R; Retamal J; Cortínez LI; Severino N; Kiavialaitis GE; Ospina-Tascón G; Bakker J; Hernández G; Kattan E
    Crit Care; 2024 Jul; 28(1):216. PubMed ID: 38961499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Timing of vasopressin initiation and mortality in patients with septic shock: analysis of the MIMIC-III and MIMIC-IV databases.
    Xu J; Cai H; Zheng X
    BMC Infect Dis; 2023 Apr; 23(1):199. PubMed ID: 37013474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early versus delayed administration of norepinephrine in patients with septic shock.
    Bai X; Yu W; Ji W; Lin Z; Tan S; Duan K; Dong Y; Xu L; Li N
    Crit Care; 2014 Oct; 18(5):532. PubMed ID: 25277635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early prediction of norepinephrine dependency and refractory septic shock with a multimodal approach of vascular failure.
    Conrad M; Perez P; Thivilier C; Levy B
    J Crit Care; 2015 Aug; 30(4):739-43. PubMed ID: 25900257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Septic Shock 3.0 Definition and Trials: A Vasopressin and Septic Shock Trial Experience.
    Russell JA; Lee T; Singer J; Boyd JH; Walley KR;
    Crit Care Med; 2017 Jun; 45(6):940-948. PubMed ID: 28333757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Terlipressin versus norepinephrine as infusion in patients with septic shock: a multicentre, randomised, double-blinded trial.
    Liu ZM; Chen J; Kou Q; Lin Q; Huang X; Tang Z; Kang Y; Li K; Zhou L; Song Q; Sun T; Zhao L; Wang X; He X; Wang C; Wu B; Lin J; Yuan S; Gu Q; Qian K; Shi X; Feng Y; Lin A; He X; ; Guan XD
    Intensive Care Med; 2018 Nov; 44(11):1816-1825. PubMed ID: 29971593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of early vasopressin combined with norepinephrine on short-term mortality in septic shock: A retrospective study based on the MIMIC-IV database.
    He D; Zhang L; Hu H; Gu WJ; Lu X; Qiu M; Li C; Yin H; Lyu J
    Am J Emerg Med; 2023 Jul; 69():188-194. PubMed ID: 37167890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating Vasopressor Discontinuation Strategies in Patients With Septic Shock on Concomitant Norepinephrine and Vasopressin Infusions.
    Musallam N; Altshuler D; Merchan C; Zakhary B; Aberle C; Papadopoulos J
    Ann Pharmacother; 2018 Aug; 52(8):733-739. PubMed ID: 29560736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A time-sensitive analysis of the prognostic utility of vasopressor dose in septic shock.
    Chotalia M; Matthews T; Arunkumar S; Bangash MN; Parekh D; Patel JM
    Anaesthesia; 2021 Oct; 76(10):1358-1366. PubMed ID: 33687732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between norepinephrine dose, tachycardia and outcome in septic shock: A multicentre evaluation.
    Domizi R; Calcinaro S; Harris S; Beilstein C; Boerma C; Chiche JD; D'Egidio A; Damiani E; Donati A; Koetsier PM; Madden MP; McAuley DF; Morelli A; Pelaia P; Royer P; Shankar-Hari M; Wickboldt N; Zolfaghari P; Singer M
    J Crit Care; 2020 Jun; 57():185-190. PubMed ID: 32171905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Norepinephrine dose, lactate or heart rate: what impacts prognosis in sepsis and septic shock? Results from a prospective, monocentric registry.
    Schupp T; Weidner K; Rusnak J; Jawhar S; Forner J; Dulatahu F; Brück LM; Hoffmann U; Bertsch T; Akin I; Behnes M
    Curr Med Res Opin; 2023 May; 39(5):647-659. PubMed ID: 36951515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Refractory septic shock: efficacy and safety of very high doses of norepinephrine.
    Katsaragakis S; Kapralou A; Theodorou D; Markogiannakis H; Larentzakis A; Stamou KM; Drimousis P; Bramis I
    Methods Find Exp Clin Pharmacol; 2006 Jun; 28(5):307-13. PubMed ID: 16845448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radial to femoral arterial blood pressure differences in septic shock patients receiving high-dose norepinephrine therapy.
    Kim WY; Jun JH; Huh JW; Hong SB; Lim CM; Koh Y
    Shock; 2013 Dec; 40(6):527-31. PubMed ID: 24089010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality, Morbidity, and Costs After Implementation of a Vasopressin Guideline in Medical Intensive Care Patients With Septic Shock: An Interrupted Time Series Analysis.
    Bauer SR; Sacha GL; Reddy AJ
    Ann Pharmacother; 2020 Apr; 54(4):314-321. PubMed ID: 31679395
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of norepinephrine on the outcome of septic shock.
    Martin C; Viviand X; Leone M; Thirion X
    Crit Care Med; 2000 Aug; 28(8):2758-65. PubMed ID: 10966247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of vasopressor agent in septic shock mortality. Results from the Portuguese Community-Acquired Sepsis Study (SACiUCI study).
    Póvoa PR; Carneiro AH; Ribeiro OS; Pereira AC;
    Crit Care Med; 2009 Feb; 37(2):410-6. PubMed ID: 19114885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Outcomes After Vasopressin Guideline Implementation in Septic Shock.
    Wu JY; Stollings JL; Wheeler AP; Semler MW; Rice TW
    Ann Pharmacother; 2017 Jan; 51(1):13-20. PubMed ID: 27630192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central venous pressure value can assist in adjusting norepinephrine dosage after the initial resuscitation of septic shock.
    Li DK; Du W
    Chin Med J (Engl); 2019 May; 132(10):1159-1165. PubMed ID: 30946069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between US Norepinephrine Shortage and Mortality Among Patients With Septic Shock.
    Vail E; Gershengorn HB; Hua M; Walkey AJ; Rubenfeld G; Wunsch H
    JAMA; 2017 Apr; 317(14):1433-1442. PubMed ID: 28322415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypotension Risk Based on Vasoactive Agent Discontinuation Order in Patients in the Recovery Phase of Septic Shock.
    Sacha GL; Lam SW; Duggal A; Torbic H; Reddy AJ; Bauer SR
    Pharmacotherapy; 2018 Mar; 38(3):319-326. PubMed ID: 29328496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.